Yanjun Liu, M.D., Ph.D, has served as a member of our board of directors since November, 2018. He has been Vice President of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) since 2013. He also holds the position of President of the Central Research Institute, a division of SPH. Dr. Liu serves as Chairman of the Board of Shanghai Jiaolian Medicine Research and Development Co., Ltd, a wholly owned subsidiary of SPH. Previously, Dr. Liu served as a Vice General Manager in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. from 2001 to 2012. Dr. Liu holds a Ph.D and M.D. from Second Military Medical University in Shanghai, China.